Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China SFDA Calls For Release Of Materials To Ease Hemophilia Treatment Shortage (China)

This article was originally published in PharmAsia News

Executive Summary

China's State FDA says it has asked four blood-products companies in the country to release the raw materials used to make the clotting factor VIII to help eliminate a shortage of the materials needed to treat hemophilia. The agency sent the firms a notice seeking cryoprecipitate, a frozen blood product produced from plasma, to make them available to the three companies that produce factor VIII. The shortage was caused in part to a 50 percent drop in the plasma supply last year. (Click here for more )
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel